Showing 191-200 of 1728 results for "".
MS Minute: The COVID-19 Vaccine & Vaccine Readiness in MS
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-the-covid-19-vaccine-vaccine-readiness-in-ms/31748/Evidence suggests all people with multiple sclerosis, including those on any class of disease-modifying treatment, can and should be vaccinated against COVID-19.Neuroimaging Traumatic Brain Injuries
https://practicalneurology.com/diseases-diagnoses/tbi/neuroimaging-traumatic-brain-injuries/31599/Imaging is of paramount importance to the overall care of people with TBIsOptimizing Outcomes in AAD in Community PCP and LTC Clinics
https://practicalneurology.com/programs/cme/optimizing-outcomes-in-aad-in-community-pcp-and-ltc-clinics/26712/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Clinical Use of Dementia Biomarkers to Evaluate Cognitive Deficits in People With Primary Psychiatric Disorders
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/clinical-use-of-dementia-biomarkers-to-evaluate-cognitive-deficits-in-people-with-primary-psychiatric-disorders/32101/Biomarkers may assist in identifying whether symptoms are the result of the primary psychiatric process or a neurodegenerative process.Traumatic Brain Injury in Older Adults: Epidemiology, Management, Outcomes
https://practicalneurology.com/diseases-diagnoses/tbi/traumatic-brain-injury-in-older-adults-epidemiology-management-outcomes/31987/Unique features of traumatic brain injuries in older adults and the current landscape of treatment and management optionsBuilding Better Strategies: Incorporating New AAD Treatments Into Clinical Practice
https://practicalneurology.com/programs/cme/building-better-strategies-incorporating-new-aad-treatments-into-clinical-practice/27102/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Treatment Response Assessment Tools for Relapsing Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/treatment-response-assessment-tools-for-relapsing-multiple-sclerosis/33142/The authors explore available tools for assessing treatment response in relapsing multiple sclerosis and provide practical recommendations for their use in clinical practice.Multiple Sclerosis Minute: Novel Treatment Options for Neuromyelitis Optica Spectrum Disorder
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-minute-novel-treatment-options-for-neuromyelitis-opticaspectrum-disorder/31844/Relapse prevention is critical for preventing the accumulation of disability in NMOSD and new monoclonal antibody therapies are highly effective at doing so.AAD Treatment Evolution: The Future of Emerging Therapies
https://practicalneurology.com/programs/cme/aad-treatment-evolution-the-future-of-emerging-therapies/27103/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Burden Beyond the Patient: AAD's Impact on Patients and Caregivers
https://practicalneurology.com/programs/cme/burden-beyond-the-patient-aads-impact-on-patients-and-caregivers/27094/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.